Completed PHASE1 INTERVENTIONAL NCT00307697

A Letter Intervention in Primary Care Patients to Improve Depression and Anxiety Disorders

A Randomised Controlled Trial of a Letter Intervention in Primary Care Patients to Improve Depression and Anxiety Disorders

Sponsor: Bayside Health

Conditions Anxiety Depression

Interventions receipt of copy of psychiatic assessment letter

Updated 5 times since 2017 Last updated: Nov 26, 2013 Started: Jun 30, 2006 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00307697, this PHASE1 trial focuses on Anxiety and Depression and remains completed. Sponsored by Bayside Health, it has been updated 5 times since 2006, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayside Health
Beyondblue (The National Depression Initiative)

Data source: Bayside Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia